139 related articles for article (PubMed ID: 34121706)
1. Impact of the COVID-19 pandemic on health care activities at a Uruguayan mastology unit.
Castillo C; Camejo N; Amarillo D; Rodriguez F; Vitureira F; Krygier G; Delgado L
J Cancer Res Ther; 2021; 17(2):547-550. PubMed ID: 34121706
[TBL] [Abstract][Full Text] [Related]
2. Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
Schmidt AL; Bakouny Z; Bhalla S; Steinharter JA; Tremblay DA; Awad MM; Kessler AJ; Haddad RI; Evans M; Busser F; Wotman M; Curran CR; Zimmerman BS; Bouchard G; Jun T; Nuzzo PV; Qin Q; Hirsch L; Feld J; Kelleher KM; Seidman D; Huang HH; Anderson-Keightly HM; Abou Alaiwi S; Rosenbloom TD; Stewart PS; Galsky MD; Choueiri TK; Doroshow DB
Cancer Cell; 2020 Dec; 38(6):769-770. PubMed ID: 33176161
[No Abstract] [Full Text] [Related]
3. COVID-19 and cancer care: What have we learned?: Despite the enormous challenges, researchers are sharing valuable lessons regarding evaluating risks, setting priorities, and communicating with patients during the pandemic.
Nelson B; Kaminsky DB
Cancer Cytopathol; 2020 Dec; 128(12):879-880. PubMed ID: 33264512
[No Abstract] [Full Text] [Related]
4. Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic.
Elghazawy H; Bakkach J; Zaghloul MS; Abusanad A; Hussein MM; Alorabi M; Eldin NB; Helal T; Zaghloul TM; Venkatesulu BP; Elghazaly H; Al-Sukhun S
Future Oncol; 2020 Nov; 16(31):2551-2567. PubMed ID: 32715776
[TBL] [Abstract][Full Text] [Related]
5. Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum.
McAlarnen LA; Tsaih SW; Aliani R; Simske NM; Hopp EE
Gynecol Oncol; 2021 Jul; 162(1):4-11. PubMed ID: 33994014
[TBL] [Abstract][Full Text] [Related]
6. Telemedicine health disparities in oncology care.
Wozniak AM; Rallis KS; Elkaddoum R
Future Oncol; 2021 May; 17(14):1695-1698. PubMed ID: 33631991
[No Abstract] [Full Text] [Related]
7. Risk factors and clinical outcomes of systemic cancer treatment delays in Filipino patients with solid tumor malignancy during the COVID-19 pandemic: A single tertiary center study.
Pandy JG; Maaño O; Balolong-Garcia JC; Datukan JTY
Cancer Rep (Hoboken); 2022 Feb; 5(2):e1426. PubMed ID: 34021716
[TBL] [Abstract][Full Text] [Related]
8. Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.
Viale G; Licata L; Sica L; Zambelli S; Zucchinelli P; Rognone A; Aldrighetti D; Di Micco R; Zuber V; Pasetti M; Di Muzio N; Rodighiero M; Panizza P; Sassi I; Petrella G; Cascinu S; Gentilini OD; Bianchini G
Oncologist; 2020 Jul; 25(7):e1013-e1020. PubMed ID: 32412693
[TBL] [Abstract][Full Text] [Related]
9. The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives.
Rocco N; Montagna G; Di Micco R; Benson J; Criscitiello C; Chen L; Di Pace B; Esgueva Colmenarejo AJ; Harder Y; Karakatsanis A; Maglia A; Mele M; Nafissi N; Ferreira PS; Taher W; Tejerina A; Vinci A; Nava M; Catanuto G
Oncologist; 2021 Jan; 26(1):e66-e77. PubMed ID: 33044007
[TBL] [Abstract][Full Text] [Related]
10. Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.
Frasci G; Comella P; D'Aiuto G; Budillon A; Barbarulo D; Thomas R; Capasso I; Casaretti R; Daponte A; Caponigro F; Gravina A; Maiorino L; Caratení G; Gentile A; Comella G
Breast Cancer Res Treat; 1998 May; 49(1):13-26. PubMed ID: 9694607
[TBL] [Abstract][Full Text] [Related]
11. Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period.
Ceccato F; Voltan G; Sabbadin C; Camozzi V; Merante Boschin I; Mian C; Zanotto V; Donato D; Bordignon G; Capizzi A; Carretta G; Scaroni C
J Endocrinol Invest; 2021 Aug; 44(8):1689-1698. PubMed ID: 33355915
[TBL] [Abstract][Full Text] [Related]
12. Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors?
Yildiz F; Oksuzoglu B
Future Oncol; 2020 Oct; 16(28):2191-2195. PubMed ID: 32857603
[No Abstract] [Full Text] [Related]
13. Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response.
Rittberg R; Mann A; Desautels D; Earle CC; Navaratnam S; Pitz M
Curr Oncol; 2020 Dec; 28(1):233-251. PubMed ID: 33704191
[TBL] [Abstract][Full Text] [Related]
14. Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.
Haynes SC; Kompala T; Neinstein A; Rosenthal J; Crossen S
J Diabetes Sci Technol; 2021 Sep; 15(5):986-992. PubMed ID: 33719622
[TBL] [Abstract][Full Text] [Related]
15. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
Rusthoven J; Bramwell V; Stephenson B
Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
[TBL] [Abstract][Full Text] [Related]
16. Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center.
Piedimonte S; Li S; Laframboise S; Ferguson SE; Bernardini MQ; Bouchard-Fortier G; Hogen L; Cybulska P; Worley MJ; May T
Gynecol Oncol; 2021 Jul; 162(1):12-17. PubMed ID: 33941382
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study.
Sakurada T; Bando S; Zamami Y; Takechi K; Chuma M; Goda M; Kirino Y; Nakamura T; Teraoka K; Morimoto M; Tangoku A; Ishizawa K
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1107-1114. PubMed ID: 31502114
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
[TBL] [Abstract][Full Text] [Related]
19. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
Hardman JC; Tikka T; Paleri V;
Cancer; 2021 Nov; 127(22):4177-4189. PubMed ID: 34411287
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.
Kornek GV; Ulrich-Pur H; Penz M; Haider K; Kwasny W; Depisch D; Kovats E; Lang F; Schneeweiss B; Scheithauer W
J Clin Oncol; 2001 Feb; 19(3):621-7. PubMed ID: 11157011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
